ASX 200 midday update: NAB completes acquisition, lithium miners sink, Origin tumbles

There's a lot happening on the ASX 200 today…

A male sharemarket analyst sits at his desk looking intently at his laptop with two other monitors next to him showing stock price movements

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

At lunch on Wednesday, the S&P/ASX 200 Index (ASX: XJO) is on course to start the month with a small gain. The benchmark index is currently up 0.2% to 7,225.9 points.

Here's what is happening on the ASX 200 today:

NAB completes Citi acquisition

The National Australia Bank Ltd (ASX: NAB) share price is rising on Wednesday after the bank announced the completion of its $1.2 billion acquisition of Citigroup's Australian consumer business. This acquisition includes a home lending portfolio, unsecured lending business (operating under the Citigroup brand as well as white label partner brands), retail deposits business, and private wealth management business.

Lithium miners tumble

The lithium sector is a sea of red on Wednesday. This follows bearish notes out of Credit Suisse and Goldman Sachs and news that Argentina has set a lithium reference price of US$53 per kilo. In respect to the former, as we covered here last month, Goldman has reiterated its view that lithium prices will fall heavily in the coming years. The likes of Allkem Ltd (ASX: AKE) and Pilbara Minerals Ltd (ASX: PLS) are falling particularly heavily today.

Origin withdraws guidance

The Origin Energy Ltd (ASX: ORG) share price is sinking today after the energy giant withdrew its earnings guidance. Due largely to coal supply challenges, Origin now expects its energy markets' underlying EBITDA to be between $310 million and $460 million. Previously, it was expecting $450 million to $600 million of earnings. And with management unsure how long these tough trading conditions will last, it has withdrawn its FY 2023 guidance.

Best and worst ASX 200 performers

The best performer on the ASX 200 on Wednesday has been the Nufarm Ltd (ASX: NUF) share price with a 2.5% gain. This appears to have been driven by bargain hunters buying shares after a recent decline. The worst performer has been the Pilbara Minerals share price with a 15% decline. This follows the bearish broker notes and Argentina news.

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Market News

Woman with gold nuggets on her hand.
Broker Notes

Why this surging ASX 300 gold stock is forecast to keep on giving

A leading broker forecasts more outperformance from this rocketing ASX gold stock.

Read more »

Business people discussing project on digital tablet.
Broker Notes

Buy, hold, sell: Credit Corp, PLS, and ResMed shares

Let's see what Morgans is saying about these shares this week.

Read more »

Man holding out $50 and $100 notes in his hands, symbolising ex dividend.
Dividend Investing

Passive income: How much do you need to invest to make $500 per month?

This is how much you’d need to unlock significant passive income.

Read more »

A male investor wearing a white shirt and blue suit jacket sits at his desk looking at his laptop with his hands to his chin, waiting in anticipation.
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the local market today.

Read more »

Scientists working in the laboratory and examining results.
Share Market News

Neuren Pharmaceuticals shares FDA meeting feedback on NNZ-2591 clinical programs

Neuren shares FDA feedback on NNZ-2591 development plans in HIE and PTHS, with next steps and management insights.

Read more »

View of a business man's hand passing a $100 note to another with a bank in the background.
Opinions

3 ASX shares I'd buy with $10,000 today

Here's where I'd put $10,000 right now.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

Three children wearing athletic short and singlets stand side by side on a running track wearing medals around their necks and standing with their hands on their hips.
Share Gainers

Here are the top 10 ASX 200 shares today

Investors enjoyed a strong hump day session today.

Read more »